Coronary artery disease potentiates response to dofetilide for rhythm control of atrial fibrillation.


BACKGROUND Dofetilide, a class III antiarrhythmic, is one of the few alternatives to amiodarone in patients with atrial fibrillation (AF) and heart failure or coronary artery disease (CAD). While amiodarone has been extensively studied, little is known about predictors of response to dofetilide. We sought to identify clinical parameters associated with… (More)
DOI: 10.1111/j.1540-8159.2011.03245.x


2 Figures and Tables

Slides referencing similar topics